DEG6498

· Degron Therapeutics Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DEG6498, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DEG6498 in Participants With Solid Tumors [Phase 1]